{"title": "Genzyme's Lemtrada Approved in Canada for Treatment of Multiple Sclerosis", "author": null, "url": "https://www.fiercebiotech.com/biotech/genzyme-s-lemtrada%E2%84%A2-approved-canada-for-treatment-of-multiple-sclerosis", "hostname": "fiercebiotech.com", "description": "December 13, 2013 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that Health Canada has approved Lemtrada... | December 13, 2013 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that Health Canada has approved Lemtrada...", "sitename": "FierceBiotech", "date": "2013-12-13", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}